APIMEDS PHARMACEUTICALS US I (APUS) Stock Balance Sheet
NYSEARCA:APUS • US03771D1028
Current stock price
1.91 USD
+0.28 (+17.18%)
At close:
1.86 USD
-0.05 (-2.62%)
After Hours:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash | 3.50K | 410.50K | 6.20K | |||
| Other Current Assets | 9.60K | 11.60K | 0.00 | |||
| Total Current Assets | 13.10K | 422.10K | 6.20K | |||
| Non-Current Assets | ||||||
| Total Non-Current Assets | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 13.10K | 422.10K | 6.20K | |||
| LIABILITIES | ||||||
| Current Liabilities | ||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 250.00K | 0.00 | 260.00K | |||
| Accrued Expenses | 697.80K | 123.30K | 35.90K | |||
| Other Current Liabilities | 76.50K | 0.00 | 23.90K | |||
| Total Current Liabilities | 1.02M | 123.30K | 319.80K | |||
| Non-Current Liabilities | ||||||
| Long Term Debt | 346.80K | 266.90K | 400.00K | |||
| Total Non-Current Liabilities | 346.90K | 266.90K | 400.00K | |||
| TOTAL LIABILITIES | 1.37M | 390.20K | 719.80K | |||
| SHAREHOLDERS' EQUITY | ||||||
| Retained Earnings | -4.39M | -3.00M | -2.22M | |||
| Additional Paid In Capital | 2.95M | 2.83M | 1.41M | |||
| Common Shares | 79.00K | 205.50K | 100.00K | |||
| Shares Outstanding | 11.57M | 11.57M | 11.57M | |||
| Tangible Book Value per Share | -0.12 | 0.00 | -0.06 | |||
| Total Shareholders' Equity | -1.36M | 31.90K | -713.60K | |||
| TOTAL LIABILITIES AND EQUITY | 13.10K | 422.10K | 6.20K | |||
| Statistics | ||||||
| Debt/Equity | -0.26 | 8.37 | -0.56 | |||
| Current Ratio | 0.01 | 3.42 | 0.02 | |||
| Return On Assets (ROA) | -10610.69% | -184.25% | -10785.48% | |||
| Return On Equity (ROE) | N/A | -2437.93% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21